# Chlorhexidine Mouthrinse Before EBUS-TBNA

> **NCT04718922** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 112 (actual)

## Conditions studied

- Endobronchial Ultrasound

## Interventions

- **DRUG:** Chlorhexidine Gluconate 0.12 % Mouthwash

## Key facts

- **NCT ID:** NCT04718922
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-20
- **Primary completion:** 2021-06-11
- **Final completion:** 2021-12-11
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718922, "Chlorhexidine Mouthrinse Before EBUS-TBNA". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04718922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*